OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(25)
Release Date
2022
(6)
2023
(5)
2025
(4)
2024
(4)
2021
(3)
2019
(1)
2017
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice.
Not available
S-EPMC9665025
|
biostudies-literature
Cite
Direct-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statement.
Not available
S-EPMC4680136
|
biostudies-literature
Cite
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.
Not available
S-EPMC10603363
|
biostudies-literature
Cite
Examining Individual and Synergistic Contributions of PTSD and Genetics to Blood Pressure: A Trans-Ethnic Meta-Analysis.
Not available
S-EPMC8262489
|
biostudies-literature
Cite
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
Not available
S-EPMC10940093
|
biostudies-literature
Cite
Glioma progression is shaped by genetic evolution and microenvironment interactions.
Not available
S-EPMC9189056
|
biostudies-literature
Cite
The Relationship of Attention-Deficit/Hyperactivity Disorder With Posttraumatic Stress Disorder: A Two-Sample Mendelian Randomization and Population-Based Sibling Comparison Study.
Not available
S-EPMC10496427
|
biostudies-literature
Cite
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets